Key Insights from Attending ASH 2025
From Treating Blood Cancers by Blood Cancer United
January 13, 2026 · 34 min
About this episode
Dr. Lore Gruenbaum discusses key insights and breakthroughs in blood cancers from the ASH 2025 Annual Meeting.
Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC Recorded on December 18, 2025 Lore Gruenbaum, PhD Chief Scientific Officer & Senior Vice President of Research Blood Cancer United Washington, DC Join Dr. Lore Gruenbaum, Chief Scientific Officer and Senior Vice President of Research at Blood Cancer United, to provide practice-changing data in hematologic malignancies from the 67th American Society of Hematology (ASH) Annual Meeting. Explored are breakthroughs in multiple myeloma, AML, CLL, and advances in cell therapy. Discussion also covers the growing use of artificial intelligence to accelerate precision medicine, spotlighting the Blood Cancer United Beat AML® Master Clinical Trial as a model for AI-driven trial design and real-time clinical decision-making. Tune in today for the key takeaways you need to know! Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients
People in this episode
Guest: Lore Gruenbaum Phd
Topics covered
- hematologic malignancies
- multiple myeloma
- AML
- CLL
- cell therapy
- artificial intelligence
- precision medicine
Keywords
- ASH 2025
- Blood Cancer United
- Beat AML® Master Clinical Trial
- clinical decision-making
Mentioned in this episode
Places: Washington, DC
More episodes of Treating Blood Cancers
- Optimizing HSCT in Blood Cancers · June 2, 2026 · 39 min
- Clinical Strategies for Supporting Couples, Care Partners, and Families in Oncology Care · May 8, 2026 · 35 min
- Driving Progress in AML · April 23, 2026 · 34 min
- Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment · April 13, 2026 · 34 min
- Optimizing Outcomes in Myeloma · March 24, 2026 · 40 min
- Strategies to Navigate Expanded Access (Compassionate Use) in Treating Pediatric Oncology · March 3, 2026 · 40 min
Explore listener stats, chart rankings, contacts and more on the Treating Blood Cancers podcast page.